Associate Director, Clinical Pharmacology
Geron Corporation
Ashley Lennox, PhD, is an Associate Director of Clinical Pharmacology at Geron Corporation (Menlo Park, CA, USA). At Geron, a small oncology biotech, Ashley is the lead clinical pharmacologist for imetelstat, an oligonucleotide being developd for hematologic malignancies, and contributed to its recent US and European marketing applications. Prior to this role, she worked at Nuventra Pharma Sciences/Allucent for 4 years. Ashley completed her undergraduate degree at the University of Pittsburgh in molecular biology and her doctoral training in genetics and genomics at Duke University.